Oxitefonium

Oxitefonium

SCHEMBL29388802

CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)c1cccs1

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 13/20 0.73
CHRM3 P20309 13/20 0.73
CHRM2 P08172 12/20 0.73
CHRM4 P08173 4/20 0.73
SCN1A P35498 2/20 0.57
SCN2A Q99250 2/20 0.57
SCN3A Q9NY46 2/20 0.57
SLC6A3 Q01959 1/20 0.54
KCNH2 Q12809 1/20 0.54
MEN1 O00255 1/20 0.45
POLB P06746 1/20 0.45
KMT2A Q03164 1/20 0.45
ALDH1A1 P00352 1/20 0.44
CHRM5 P08912 2/20 0.42
CYP2D6 P10635 2/20 0.42
SIGMAR1 Q99720 1/20 0.42
PABPC1 P11940 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxitefonium SCHEMBL2733669 0.99 CHRM1 (0.76) CHRM1CHRM3CHRM2CHRM4SCN1A
Methylbenactyzium SCHEMBL669744 0.86 CHRM1 (0.97) CHRM1CHRM3CHRM2CHRM4SCN1A
Methylbenactyzium SCHEMBL8816404 0.85 CHRM1 (0.94) CHRM1CHRM3CHRM2CHRM4SCN1A
Methylbenactyzium SCHEMBL60901 0.85 CHRM1 (1.00) CHRM1CHRM3CHRM2CHRM4SCN1A
Methylbenactyzium SCHEMBL8446490 0.83 CHRM1 (0.95) CHRM1CHRM3CHRM2CHRM4SCN1A
SCHEMBL5399482 0.82 CHRM3 (0.51) CHRM1CHRM3CHRM2CHRM4MEN1
Penthienate SCHEMBL31393386 0.76 CHRM1 (0.68) CHRM1CHRM3CHRM2CHRM4SCN1A
Penthienate SCHEMBL250881 0.76 CHRM1 (0.67) CHRM1CHRM3CHRM2CHRM4SCN1A
SCHEMBL28905886 0.76 CHRM3 (0.54) CHRM1CHRM3CHRM2MEN1POLB
SCHEMBL16053656 0.76 CHRM3 (0.47) CHRM1CHRM3CHRM2CHRM4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220047505-A1 Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration STI PHARMA, LLC (US) 2022-02-17 US disclosed